Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Proteome Research

• Publication date

  2005-02-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/PR049836HPMID 15822896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.

  2004cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Protein degradation and protection against misfolded or damaged proteins

  2003cited by this paper
• Are ubiquitination pathways central to Parkinson's disease?

  2003cited by this paper
• Chromaffin cell death induced by 6‐hydroxydopamine is independent of mitochondrial swelling and caspase activation

  2003cited by this paper
• 6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats.

  2002cited by this paper
• Glutathione decreases in dopaminergic PC12 cells interfere
with the ubiquitin protein degradation pathway: relevance 
for Parkinson's disease?

  2002cited by this paper
• Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.

  2001cited by this paper
• 6-Hydroxydopamine Increases Ubiquitin-Conjugates and Protein Degradation: Implications for the Pathogenesis of Parkinson's Disease

  2001cited by this paper
• Acute and chronic haloperidol treatments increase parkin mRNA levels in the rat brain.

  2001cited by this paper
• L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.

  2000cited by this paper
• α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

  2000cited by this paper
• Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

  2000cited by this paper
• What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?

  2000cited by this paper
• The measurement of ubiquitin and ubiquitinated proteins

  1999cited by this paper
• Ubiquitin, cellular inclusions and their role in neurodegeneration.

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Genetic classification of primary neurodegenerative disease.

  1998cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Ubiquitin in homeostasis, development and disease

  1995cited by this paper
• Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.

  1991cited by this paper

• Neuroprotective effect of the herbal pair Coptidis Rhizoma-Cinnamomi Cortex against 6-OHDA-induced Parkinson's disease rats through promotion of autophagy via the PI3K/AKT/mTOR pathway.

  2025cites this paper
• Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks

  2021cites this paper
• Molecular imaging mass spectrometry for probing protein dynamics in neurodegenerative disease pathology

  2018cites this paper
• Recent advances in applying mass spectrometry and systems biology to determine brain dynamics

  2017cites this paper
• The use of MALDI‐MSI in the investigation of psychiatric and neurodegenerative disorders: A review

  2016cites this paper
• Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus

  2014cites this paper
• Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology

  2014cites this paper
• Proteomics imaging and the kidney.

  2013cites this paper
• MALDI Imaging Technology Application in Neurosciences: From History to Perspectives

  2012cites this paper
• Expression Profiling in Neuroscience

  2012cites this paper
• MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue

  2011cites this paper
• MALDI Imaging Mass Spectrometry for Investigating the Brain

  2011cites this paper
• DOPAMINE RECEPTOR SUBTYPES, IP3, cAMP AND cGMP FUNCTIONAL REGULATION IN PARKINSONISM INDUCED BY UNILATERAL INFUSION OF ROTENONE IN RATS: RECOVERY WITH BONE MARROW CELLS, SEROTONIN AND GABA SUPPLEMENTATION

  2011cites this paper
• Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of Unilateral 6-hydroxydopamine induced Parkinson's rats: Effect of 5-HT, GABA and bone marrow cell supplementation

  2011cites this paper
• MALDI Imaging and Profiling Mass Spectrometry in Neuroproteomics

  2010cites this paper
• Proteomics in Parkinson’s disease: current trends, translational snags and future possibilities

  2010cites this paper
• Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease

  2010cites this paper
• Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease*S

  2009cites this paper
• MITICS (MALDI Imaging Team Imaging Computing System): a new open source mass spectrometry imaging software.

  2008cites this paper
• Molecular MALDI imaging: An emerging technology for neuroscience studies

  2008cites this paper
• MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting.

  2008cites this paper
• Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics

  2008cites this paper
• Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.

  2007cites this paper
• Imaging mass spectrometry at cellular length scales

  2007cites this paper
• Proteomic analysis of striatal proteins in the rat model of l‐DOPA‐induced dyskinesia

  2007cites this paper
• Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry

  2007cites this paper
• In Vitro Imaging Techniques in Neurodegenerative Diseases

  2007cites this paper
• Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.

  2007cites this paper
• Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis.

  2007cites this paper
• Neuropeptidomics: MS applied to the discovery of novel peptides from the brain.

  2007cites this paper
• MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis.

  2007cites this paper
• High-resolution MALDI imaging mass spectrometry allows localization of peptide distributions at cellular length scales in pituitary tissue sections

  2007cites this paper
• New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.

  2006cites this paper
• Molecular imaging of thin mammalian tissue sections by mass spectrometry.

  2006cites this paper
• Chapter 1 Emerging technologies—the way forward on improving protein analysis

  2005cites this paper
• Current Awareness on Comparative and Functional Genomics

  2005cites this paper
• Proteomics: A new research area for the biomedical field

  2005cites this paper